Newsletter
Every new paper in this field, in your inbox.
Researchers bring a game-changer to minimal access liver surgery (MALS) for hepatocellular carcinoma (HCC). Testing the waters with laparoscopic and robotic ultrasound-guided compression anatomical resection (C-AR), they aced it with 10 patients—no post-op hiccups. This technique, known in open surgery, now waltzes into MALS, promising…
Discharging patients on weekends following pancreatic surgery, a practice previously linked to increased mortality, was found to have no significant impact on the 30-day readmission rate. The study, encompassing 2,042 patients, revealed similar readmission rates between weekend and weekday discharges, suggesting that with careful clinical…
Researchers crafted an innovative machine learning (ML) model for forecasting clinically relevant postoperative pancreatic fistula (CR-POPF) after pancreaticoduodenectomy. The ML model consistently outshone the existing modified fistula risk score (MFRS) in both internal and external validations, proving its versatility and efficacy in enhancing CR-POPF prediction.…
For pancreatic body cancers, researchers compared distal pancreatectomy with portal vein resection (DP-PVR) to the more common pancreaticoduodenectomy with PVR. Despite DP-PVR having higher occlusion and complication rates, both approaches showed similar survival outcomes. Meticulous surgical techniques, including various reconstruction methods for DP-PVR, were crucial.…
In the post-distal pancreatectomy (DP) landscape, researchers explored the rare territory of clinically relevant post-pancreatectomy hemorrhage (CR-PPH). Among 1,188 patients, 5.5% encountered CR-PPH, marked by increased 90-day mortality and morbidity. Prolonged operative time and co-existing postoperative pancreatic fistula independently heightened CR-PPH risk. Strikingly, the failure-to-rescue…
In the realm of pancreatic branch-duct intraductal papillary mucinous neoplasms (bd-IPMNs), spotting malignancy is tricky. However, researchers delving into 58 cases discovered a game-changer. The standardized uptake value (SUV) from FDG-PET/CT, specifically the tumor-to-blood pool ratio (TBR), emerged as a potent indicator of malignancy. Correlating…
The study delves into the uncertain territory of neoadjuvant therapy (NAT) for ampullary (AA) and duodenal adenocarcinoma (DA). Analyzing 15 retrospective studies, no clear survival differences were found between NAT and upfront surgery. While some studies hinted at benefits like increased pathologic response, overall evidence…
In a randomized trial involving 102 patients with chronic liver disease undergoing hepatectomy, remote ischemic preconditioning's anticipated liver-protective benefits were not realized. Despite inducing preconditioning through upper extremity cycles of ischemia and reperfusion, the study showed no significant reduction in postoperative transaminase levels. The results…
In pancreatic cancer patients receiving FOLFIRINOX, tumor size reduction significantly increased resectability and pathologic response. Normalization of carbohydrate antigen 19-9 levels predicted resectability, lower recurrence risk, and improved survival. Postoperative antigen 19-9 rise, following prior normalization after neoadjuvant therapy, signaled heightened recurrence risk and poorer…
Patients with early-stage recurrent hepatocellular carcinoma and sarcopenia face significantly lower overall and recurrence-free survival rates, regardless of treatment type. Sarcopenia emerges as an independent prognostic factor, suggesting a crucial role in long-term outcomes. Notably, impaired host immunity, evidenced by low levels of tumor-infiltrating lymphocytes,…
